Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCommunisis PLC Regulatory News (CMS)

  • There is currently no data for CMS

Form 8.3 - Communisis plc

7 Nov 2018 16:06

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: UBAM Variable Capital Investment Company Luxembourg (UBAM SICAV)

Manco : UBP Asset Management (Europe) SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

UBAM Europe Small Cap Equity (sub-fund of UBAM SICAV)
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Communisis plc

ISIN: GB0006683238

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: NA
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/11/2018 (in addition the UBAM has dealt on previous dates during the offer period as attached at the end of the form).
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N0

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 25p Ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 2,125,397 1.01
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

2,125,397 1.01

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
25p Ordinary Sale 5661 70.9p

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
- - - - -

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit
- - - - - - - -

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit
- - - - -

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)
-

-

- -

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 6/11/2018
Contact name: Pierre Berger
Telephone number*: 41 58 819 2893

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Previously undisclosed trades:

Purchases and sales

Date of dealing Class of relevant security Purchase/sale Number of securities Price per unit
05/11/2018 25p Ordinary Sale 44,877 70.9
02/11/2018 25p Ordinary Sale 113,747 70.9
01/11/2018 25p Ordinary Sale 127,878 70.9
31/10/2018 25p Ordinary Sale 142,312 70.9

View source version on businesswire.com: https://www.businesswire.com/news/home/20181107005654/en/

Copyright Business Wire 2018

Date   Source Headline
1st Jul 20117:00 amPRNDirector Declaration
29th Jun 20114:03 pmRNSNotice of Results
22nd Jun 20112:59 pmPRNHolding(s) in Company
14th Jun 20113:41 pmRNSAcquisition
5th May 20113:15 pmPRNAGM Results; Docs lodged FSA; Resolutions passed
27th Apr 20112:41 pmPRNDirector/PDMR Shareholding
27th Apr 201111:48 amPRNDirector/PDMR Shareholding
21st Apr 20117:00 amRNSInterim Management Statement
20th Apr 20119:47 amPRNHolding(s) in Company
13th Apr 20115:02 pmPRNHolding(s) in Company
6th Apr 20119:33 amPRNAnnual Information Update
5th Apr 20114:15 pmPRNDirector/PDMR Shareholding
5th Apr 20112:06 pmPRNBlocklisting - Interim Review
5th Apr 201111:40 amPRNHolding(s) in Company
31st Mar 20114:14 pmPRNHolding(s) in Company
28th Mar 20115:00 pmPRNStatement re AR mailing; FSA lodging; AGM; Dividend;DTR4
14th Mar 20115:11 pmPRNHolding(s) in Company
3rd Mar 20117:00 amRNSPreliminary Results
20th Jan 20114:07 pmPRNHolding(s) in Company
18th Jan 20117:00 amRNSTrading Update
22nd Dec 201011:22 amPRNDirector/PDMR Shareholding
15th Dec 201011:47 amPRNHolding(s) in Company
14th Dec 20104:02 pmPRNHolding(s) in Company
14th Dec 201010:39 amPRNHolding(s) in Company
24th Nov 20105:00 pmPRNHolding(s) in Company
23rd Nov 20101:15 pmPRNHolding(s) in Company
19th Nov 20102:13 pmPRNHolding(s) in Company
19th Nov 20107:00 amRNSStrategy Update
11th Nov 20107:00 amRNSBarclays Contract Renewal
1st Nov 20104:37 pmPRNHolding(s) in Company
1st Nov 20107:00 amRNSInterim Management Statement
29th Oct 20103:33 pmPRNHolding(s) in Company
12th Oct 20109:00 amRNSContract Win
8th Oct 20104:19 pmPRNHolding(s) in Company
1st Oct 201011:55 amPRNBlocklisting - Interim Review
28th Sep 20104:40 pmRNSSecond Price Monitoring Extn
28th Sep 20104:35 pmRNSPrice Monitoring Extension
28th Sep 20109:00 amRNSCommunisis selects ExactTarget
10th Sep 20109:00 amRNSBoard Change
8th Sep 20105:00 pmPRNHolding(s) in Company
8th Sep 20105:00 pmPRNHolding(s) in Company
3rd Sep 20104:26 pmPRNHolding(s) in Company
26th Aug 20107:00 amRNSInterim Results
18th Aug 201011:56 amPRNHolding(s) in Company
21st Jul 20104:27 pmPRNHolding(s) in Company
20th Jul 201010:50 amPRNHolding(s) in Company
9th Jul 20104:17 pmPRNHolding(s) in Company
7th Jul 20107:00 amRNSTrading update and change in segmental reporting
2nd Jul 20102:08 pmPRNHolding(s) in Company
28th Jun 20108:46 amPRNDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.